Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
52°
Rain
Toggle navigation
Menu
Subscribe
Home
News
Local News
Sports
Entertainment
Obituaries
Photos
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Merck & Co
(NY:
MRK
)
76.83
USD
-0.24 (-0.31%)
Streaming Delayed Price
Updated: 7:18 AM EST, Jan 28, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Merck & Co
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Here's Why Amazon Will Never Be a Dow Jones Industrials Stock
Today 7:07 EST
One of the world's most important businesses is being ignored by one of the most important indexes.
Tags
MRK
CSCO
BA
From
Motley Fool
Noteworthy ETF Inflows: XLV, JNJ, MRK, PFE
January 27, 2021
Symbols mentioned in this story: XLV, JNJ, MRK, PFE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''...
Tags
ETFs
From
ETF Channel
Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity and Reducing Preventable Maternal Deaths in the US
January 27, 2021
Merck Announces Second Cohort of Safer Childbirth Cities Organizations Committed to Improving Maternal Health Equity in the US
From
Business Wire News Releases
The January Effect
January 27, 2021
There have been a small number of consistent alpha-creating axioms in the U.S. stock market over time.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Merck Announces Second-Quarter 2021 Dividend
January 26, 2021
Merck Announces Second-Quarter 2021 Dividend
From
Business Wire News Releases
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Investigational Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P 2021
January 26, 2021
Merck Presents Interim Findings from Phase 2a Clinical Trial Evaluating Once-Monthly Oral Islatravir for the Prevention of HIV-1 Infection at HIVR4P
From
Business Wire News Releases
The Daily Biotech Pulse: Novartis Misses, J&J Beats In Big Pharma Earnings, Vaccine Developer CureVac Taps Equity Market
January 26, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
News
AUPH
VAR
From
Benzinga
Merck Just Scrapped Its Coronavirus Vaccines — Is Merck Stock A Buy?
January 26, 2021
Merck stock dipped in late January after the Dow Jones pharmaceutical company scrapped development of two "inferior" coronavirus vaccines. Is Merck stock a buy?
From
Investor's Business Daily
European Commission Approves KEYTRUDA® (pembrolizumab) as First-Line Treatment in Adult Patients With Metastatic Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Colorectal
January 26, 2021
European Commission Approves KEYTRUDA as First-Line Treatment in Adult Patients With Metastatic MSI-H or dMMR Colorectal Cancer
From
Business Wire News Releases
Warren Buffett's 3 Biggest Stock Picks for 2021
January 26, 2021
Here's what the Oracle of Omaha is betting on for the coming year.
Tags
AAPL
BAC
GS
From
Motley Fool
Trade War Coming
January 25, 2021
There is a trade war coming between Germany and the USA because of rivalry on stimulus for the COVID epidemic.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Merck Gives Up on Coronavirus Vaccines
January 25, 2021
The company will focus on antiviral and anti-inflammatory treatments for patients infected with COVID-19.
Tags
Market News
MRK
From
Motley Fool
Dow Pares Big Loss, Nasdaq Hits New High As Apple Stock Rallies Ahead Of Earnings
January 25, 2021
Key indexes closed mixed Monday, as the Nasdaq hit a fresh closing high and the Dow Jones Industrial Average trimmed most of a 432-point loss.
From
Investor's Business Daily
Biden to reinstate travel bans amid fears about new variants as global case tally heads toward 100 million
January 25, 2021
The global tally of confirmed cases of the coronavirus-borne illness COVID-19 headed closer to 100 million on Monday with the U.S. accounting for a quarter of that total, as President Joe Biden...
Tags
MRK
Health/Care
UK:AZN
From
MarketWatch
Merck Scraps Development Of 'Inferior' Covid Vaccines; Shares Dip
January 25, 2021
Merck stock dipped Monday after the company scrapped development of two coronavirus vaccines that the company said proved inferior to already authorized drugs by other pharma players.
From
Investor's Business Daily
ROCE Insights For Merck & Co
January 25, 2021
Merck & Co (NYSE:MRK) posted a 0.42% decrease in earnings from Q2. Sales, however, increased by 15.44% over the previous quarter to ...
Tags
Market News
News
BZI/ROCE
From
Benzinga
Thinking about trading options or stock in Niu Technologies, Regeneron Pharmaceuticals, General Electric, Merck, or Axon Enterprise?
January 25, 2021
InvestorsObserver issues critical PriceWatch Alerts for NIU, REGN, GE, MRK, and AAXN.
From
PR Newswire
Merck Ends Work On COVID-19 Vaccines, Still Working On Therapeutic Candidates
January 25, 2021
Merck announced that the company is discontinuing the development of its SARS-CoV-2/COVID-19 vaccine candidates, V590 and V591.
Tags
Pharma/Biotech
Healthcare
Stocks / Equities
From
Blogs - TalkMarkets
Dow Jones Today, Futures Mixed As Merck Exits Covid Vaccine Race; Apple, Microsoft, AMD Rise Ahead Of Earnings
January 25, 2021
SciPlay and Regeneron were early leaders, Apple led the Dow Jones today as stock futures geared for the heaviest week of the Q4 reporting season.
From
Investor's Business Daily
Merck Drops COVID-19 Vaccine Studies After Phase 1 Data Churn Out Inferior Efficacy Results
January 25, 2021
Merck & Co., Inc. (NYSE: MRK), which was a late entrantto the COVID-19 vaccine fray, has dropped out of the race, and has ...
Tags
MRNA
Benzinga
PFE
From
Benzinga
Implied FTXH Analyst Target Price: $30
January 25, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Stock futures rise ahead of big week for tech earnings
January 25, 2021
Stock-index futures trade higher Monday, finding support ahead of a busy week of earnings that features results from Apple Inc., Tesla Inc. and Facebook Inc.
Tags
ES00
NQ00
SPX
From
MarketWatch
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
January 25, 2021
Merck Discontinues Development of SARS-CoV-2/COVID-19 Vaccine Candidates; Continues Development of Two Investigational Therapeutic Candidates
From
Business Wire News Releases
Embrace the ProShares Pet Care ETF as People Add Pets to the Family
January 25, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>More people have pets -- and are spending more on their pets. The PAWZ...
Tags
MRK
ETF Investing
CVET
From
InvestorPlace
The Week Ahead In Biotech (Jan 24-30): J&J, Lilly to Kickstart Big Pharma Earnings, Amgen FDA Decision and More
January 23, 2021
Biopharma stocks advanced yet again in the week ended Jan. 22, with the change of guard at the White House generating broader market ...
Tags
JNJ
RYTM
ABMD
From
Benzinga
Why Moderna's COVID Vaccine Is Just the Tip of the Iceberg
January 23, 2021
The biotech has a promising -- and expanding -- pipeline.
Tags
MRNA
MRK
AZN
From
Motley Fool
Bristol Myers Stock Is Eyeing A Buy Point At A 5-Year High — Is It A Buy?
January 22, 2021
Bristol Myers Squibb is poised for double-digit growth in 2020, thanks to its acquisition of Celgene. And, BMY stock is now trading near a five-year high. So, is BMY stock a buy?
From
Investor's Business Daily
The 7 Best Healthcare Stocks to Buy for 2021
January 20, 2021
<p><a rel="nofollow" href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice & Trading Tips</a></p> <p>Politics is a wildcard that can negatively impact healthcare stocks. But...
Tags
XLV
MRK
JNJ
From
InvestorPlace
Merck Canada and MaRS Team Up to Launch Lung Cancer Innovation Challenge
January 20, 2021
From
PR Newswire
The Daily Biotech Pulse: FDA Greenlights Merck's Heart Failure Drug, Histogen Hit With Clinical Hold, Aptorum Gets Nod For Commencing Human Study
January 20, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
BDSX
CALT
DTIL
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.